Antiphospholipid Syndrome

Alegria Monotests

Pure Excellence in
APS Diagnostics

 

Highlights of Alegria Monotests for APS Diagnostics:

Identification

Largest Alegria Monotest portfolio for random access determination of antibodies against phospholipids and phospholipid-binding proteins

Identification

Superior proprietary antigen coating procedure

Identification

Use of human beta-2-glycoprotein I as a cofactor in Alegria aPL Monotests

Identification

Excellent diagnostic efficiency and accuracy

Identification

High reproducibility and lot-to-lot consistency for robust and reliable test results

Identification

Calibration with internationally recognized standards (Harris sera, Sapporo standards)

Identification

ELISA-based Alegria Monotests in compliance with the latest ACR/EULAR APS classification criteria 2023

Identification

Economical all-in-one Alegria Monotests, particularly suited for small series

Identification

Unique flexibility with Alegria 2 for optimal workflow efficiency
antiphospholipid-syndrome
antiphospholipid-syndrome